Showing 1511-1520 of 2527 results for "".
- With New Applicator, Cryolipolysis is an Option for Male Pseudogynecomastiahttps://modernaesthetics.com/news/withnew-applicator-cryolipolysis-is-an-option-for-male-pseudogynecomastia/2472059/Thanks to a conformable surface applicator, cryolipolysis can be a safe and effective way to treat male pseudogynecomastia, according to a recent
- New Mouse Model Suggests Mitochondria Are Reversible Regulators of Wrinkling, Hair Losshttps://modernaesthetics.com/news/new-mouse-model-suggests-mitochondria-are-reversible-regulators-of-wrinkling-hair-loss/2472060/A new mouse model may one day allow scientists to reverse age-associated wrinkles and hair loss. When a mutation leading to mitochondrial dysfunction is induced, the mouse develops wrinkled skin and extensive, visible hair loss in a matter of weeks, but when the mitochondrial function is
- TempSure Vitalia from Cynosure Hits North American Markethttps://modernaesthetics.com/news/tempsure-vitalia-from-cynosure-hits-north-american-market/2472068/Hologic's Cynosure division has launched TempSure™ Vitalia in North America. TempSure Vitalia is an FDA-cleared and Health Canada-approved advanced radiofrequency treatment that delivers therapeutic heat to inter
- Alana Sine Appointed Chief Financial Officer at Merz North Americahttps://modernaesthetics.com/news/alana-sine-appointed-chief-financial-officer-at-merz-north-america/2472072/Merz North America has appointed Alana Sine to Chief Financial Officer (CFO), Merz North America. Ms. Sine has served as interim CFO since March 2018. Ms. Sine will lead the finance function for North America, overseeing financial report
- Modern Aesthetics® Announces New Tweet Chat Series -- #RealDealAestheticshttps://modernaesthetics.com/news/modern-aesthetics-announces-new-tweet-chat-series-realdealaesthetics/2472073/Modern Aesthetics® magazine is launching a new Tweet chat series -- #RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist Todd E. Schlesinger, MD. The first Tweet chat focuses on filler selection in a r
- Revance Vet Tapped as New Evolus CFOhttps://modernaesthetics.com/news/revance-vet-tapped-as-new-evolus-cfo/2472086/Lauren Silvernail is the new Chief Financial Officer and Executive Vice President, Corporate Development at Evolus, Inc. Silvernail joins Evolus from Revance Therapeutics where she most recently served as Chief Financial Officer and Chief Business Officer. Prior to her time at Revance The
- Restylane Lyft Now FDA-Approved for Handshttps://modernaesthetics.com/news/restylane-lyft-now-fda-approved-for-hands/2472088/The US Food and Drug Administration has approved Restylane Lyft for use on the dorsal hands of people older then 21, making it the first hyaluronic acid (HA) injectable gel approved for this use. Radiesse (Calcium Hydroxylapatite) is also approved for the correction of lost
- Sciton Names New Leadership Teamhttps://modernaesthetics.com/news/sciton-names-new-leadership-team/2472093/Sciton has an all new leadership team. The new Sciton leaders are: Aaron Burton, Chief Operating Officer Todd Sternbach, Vice President of Strategic Sales Initiatives David Percival, Vice President / General Manager of Sciton Intern
- Carrie Strom is Allergan's New Senior Vice President, U.S. Medical Aestheticshttps://modernaesthetics.com/news/carrie-strom-is-allergans-new-senior-vice-president-us-medical-aesthetics/2472094/Carrie Strom is Allergan’s new Senior Vice President, U.S. Medical Aesthetics, a portfolio of brands including BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® Collection of Fillers, Natrelle® col
- New Merz Survey Highlights Misconceptions about Tattoo Removalhttps://modernaesthetics.com/news/new-merz-survey-highlights-misconceptions-about-tattoo-removal/2472104/More than four in five adults with (86 percent) and without (82 percent) tattoos have misconceptions about tattoo removal, including confusion regarding side effects, cost and removability, according to a new Merz survey. In addition to not knowing how the process works, many underestimat